The UKs NICE recommended semaglutide for adults with established CVD and BMI 27 kg/m in March 2025, opening NHS access to more than 1 million patients
Thiazide diuretics and loop diuretics carry additional consideration because they can affect electrolyte balance, and GLP-1 drugs may influence fluid retention patterns
The weight-loss drug everyone was talking about is suddenly within reach, but what does this mean for patients
For weight loss, insurers sometimes want to see proof of a healthy diet and exercise routine before they approve the medication
The majority of the reported events occurred in patients who experienced gastrointestinal reactions leading to dehydration such as nausea, vomiting, or diarrhea [see Adverse Reactions (6.1)]
it does not mean the medication has leaked out or that the injection was done incorrectly